How much does a complete course of bedaquiline cost?

Bedaquiline (Bedaquiline) is a new anti-tuberculosis drug mainly used to treat multidrug-resistant tuberculosis (MDR-TB). At present, the drug has been officially launched in China and has been included in the national medical insurance directory, which greatly reduces the cost of treatment for patients. Patients can purchase bedaquiline at public hospitals or infectious disease hospitals with tuberculosis specialties, and receive partial cost reduction through the medical insurance reimbursement mechanism. The specific medical insurance reimbursement ratio and actual price vary depending on regional policies. It is recommended to go to the local hospital pharmacy for detailed consultation.

The standard recommended course of treatment for bedaquiline is 24 weeks, which is approximately 6 months. Routine usage is 1 to 2 weeks 400mg taken daily, Starting from 3weeks, 3times, 200mg each time, for 22 weeks. A total of approximately 18800mg of bedaquiline is required for the entire course of treatment, which can effectively control drug-resistant tuberculosis bacteria and improve the cure rate. Based on this dose estimate, patients need approximately 84 tablets200mg of medicine to complete a complete course of treatment.

Without considering medical insurance reimbursement, the market price of the original version of bedaquiline (developed by Johnson & Johnson) is approximately more than 10,000 yuan per course of treatment. Prices fluctuate slightly, and some hospitals may also have small price differences. If calculated based on the specifications of 200mg, patients need to purchase about 3 boxes to 4 boxes, and the price of a single box is around three to four thousand yuan. After medical insurance reimbursement, the actual burden may be reduced to less than a few thousand yuan, greatly reducing financial pressure.

For patients who have difficulty purchasing drugs domestically or who are not covered by medical insurance, overseas generic versions may also be considered. At present, generic bedaquiline has been launched in India. The common specifications are the same as those of the original product, and the price is about RMB 2,000 to 3,000. This type of generic medicine has similar ingredients to the original medicine, but is more affordable. It is one of the important choices for many low- and middle-income patients. It needs to be reminded that patients should purchase generic drugs through regular channels and use them under the guidance of doctors to ensure safety and efficacy.